J Filderman
Impact in
- Immunology top 5%
- interferon and immune responses
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- interferon and immune responses 4
- Immunotherapy and Immune Responses 2
- Immune cells in cancer 2
- Galectins and Cancer Biology 1
- Toxin Mechanisms and Immunotoxins 1
- Oncology 4
- Cytokine Signaling Pathways and Interactions 2
- Chemokine receptors and signaling 1
- Co-authors
- Walter J. Storkus (5 shared papers)Manoj Chelvanambi (2 shared papers)Jason J. Luke (1 shared paper)Afsaneh Amouzegar (1 shared paper)Lyndsay Avery (1 shared paper)Larry Kane (1 shared paper)Andrea L. Szymczak-Workman (1 shared paper)Kris F. Sachsenmeier (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)Vaccines (1 paper)Proceedings of the National Academy of Sciences (1 paper)The Journal of Immunology (1 paper)Cancers (1 paper)
- Partner nations
- United StatesJordan
In The Last Decade
J Filderman
7 papers receiving 555 citations
J Filderman's Hit Papers
Peers
Comparison fields: 5 of 44
- Immunology 421
- Oncology 222
- Infectious Diseases 82
- Radiology, Nuclear Medicine and Imaging 82
- Molecular Biology 186
Countries citing papers authored by J Filderman
This map shows the geographic impact of J Filderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Filderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Filderman more than expected).
Fields of papers citing papers by J Filderman
This network shows the impact of papers produced by J Filderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Filderman. The network helps show where J Filderman may publish in the future.
Co-authors
The 25 scholars most cited alongside J Filderman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | STING Agonists as Cancer Therapeutics Hit paper breakdown → | 2021 | 313 |
| 2 | 2018 | 124 | |
| 3 | 2017 | 90 | |
| 4 | 2021 | 31 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 1 |
About J Filderman
J Filderman is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 7 papers that have together received 566 indexed citations. Recurring topics across this work include interferon and immune responses (4 papers), Immunotherapy and Immune Responses (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Immune cells in cancer (2 papers), Galectins and Cancer Biology (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), Chemokine receptors and signaling (1 paper) and Inflammasome and immune disorders (1 paper). The work is most often cited by research in Immunology (421 citations), Oncology (222 citations), Infectious Diseases (82 citations), Radiology, Nuclear Medicine and Imaging (82 citations) and Molecular Biology (186 citations). J Filderman has collaborated with scholars based in United States and Jordan. Frequent co-authors include Walter J. Storkus, Manoj Chelvanambi, Jason J. Luke, Afsaneh Amouzegar, Lyndsay Avery, Larry Kane, Andrea L. Szymczak-Workman, Kris F. Sachsenmeier, Yariv Mazor and Anna M. Hansen. Their work appears in journals such as Frontiers in Immunology, Vaccines, Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.